China’s drug regulator gives nod to HPV vaccine for men
- Posted on January 8, 2025
- By Financial Express
- 2 Views
China’s drug regulator gives nod to HPV vaccine for men
Merck & Co’s HPV vaccine for men has been approved by China’s medical products administration, providing a boost to the company in a key market. The vaccine, which can now be used for males aged 9-26 years, has been a top growth driver for Merck, along with its cancer treatment Keytruda.
